The ADHD trial results for 5619 were worse and another ADHD trial reports in Q3 12. I think this trial is unlikely to be positive. I agree with you. Nothing compelling in the pipeline to consider TRGT right now.
BTW I should add that the schizo trial was partly conducted in India. One of your two favorite countries to conduct clinical trials in:)
Market Data 
Markets 
AI
